Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Drug mechanism

Structural insights into SV2A and the mechanism of racetam anticonvulsants

Racetam anticonvulsants, such as levetiracetam, are widely prescribed to treat and prevent seizures. Despite decades of clinical use, their mechanism of action remains unclear. Two studies now reveal the structure of the racetam-binding protein SV2A in complex with anticonvulsant drugs, providing insights into their mechanism of action and the physiology of neurotransmission.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Structure of the synaptic vesicle glycoprotein SV2A bound to racetam anticonvulsants.

References

  1. Yamagata, A. et al. Nat. Commun. 15, 3027 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Mittal, A. et al. Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-024-01335-1 (2024).

  3. Löscher, W., Gillard, M., Sands, Z. A., Kaminski, R. M. & Klitgaard, H. CNS Drugs 30, 1055–1077 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Buckley, K. & Kelly, R. B. J. Cell Biol. 100, 1284–1294 (1985).

    Article  CAS  PubMed  Google Scholar 

  5. Bajjalieh, S. M., Peterson, K., Shinghal, R. & Scheller, R. H. Science 257, 1271–1273 (1992).

    Article  CAS  PubMed  Google Scholar 

  6. Feany, M. B., Lee, S., Edwards, R. H. & Buckley, K. M. Cell 70, 861–867 (1992).

    Article  CAS  PubMed  Google Scholar 

  7. Crowder, K. M. et al. Proc. Natl Acad. Sci. USA 96, 15268–15273 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lynch, B. A. et al. Proc. Natl Acad. Sci. USA 101, 9861–9866 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Drew, D., North, R. A., Nagarathinam, K. & Tanabe, M. Chem. Rev. 121, 5289–5335 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Madeo, M., Kovács, A. D. & Pearce, D. A. J. Biol. Chem. 289, 33066–33071 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Nowack, A., Yao, J., Custer, K. L. & Bajjalieh, S. M. Am. J. Physiol. Cell Physiol. 299, C960–C967 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Dong, M. et al. Science 312, 592–596 (2006).

    Article  CAS  PubMed  Google Scholar 

  13. Benoit, R. M. et al. Nature 505, 108–111 (2014).

    Article  PubMed  Google Scholar 

  14. Budzinski, K. L. et al. Biophys. J. 97, 2577–2584 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

M.M.B. is supported by a fellowship award from the Leon Levy Foundation and by the National Institutes of Health (T32GM140935). E.R.C. is an investigator of the Howard Hughes Medical Institute and is supported by the National Institutes of Health (R01MH061876 and R35NS097362).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Mazdak M. Bradberry or Edwin R. Chapman.

Ethics declarations

Competing interests

The authors have no competing interests to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bradberry, M.M., Chapman, E.R. Structural insights into SV2A and the mechanism of racetam anticonvulsants. Nat Struct Mol Biol 31, 1818–1820 (2024). https://doi.org/10.1038/s41594-024-01430-3

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41594-024-01430-3

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research